Using The Lung
To Heal Itself
Novel peptide therapeutics
for chronic lung diseases
Eldec has discovered naturally-occurring peptides in the lung which inhibit inflammation, tissue remodeling and fibrosis. These peptides are further optimized to increase potency and make them better drug candidates.
Eldec’s lead ELD607 is a first-in-class modulator of Orai1, a key gatekeeper for inflammation and tissue remodeling. In multiple animal models of chronic lung disease, ELD607 has shown an unprecedented reversal of existing lung damage.